BeOne Medicines (ONC) News Today $288.18 -10.11 (-3.39%) As of 08/8/2025 04:00 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsTrendsBuy This Stock ONC Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period BeOne Medicines (NASDAQ:ONC) Upgraded to Strong-Buy at Wall Street Zen1 hour ago | marketbeat.comBeOne Medicines (NASDAQ:ONC) Shares Gap Down - What's Next?August 9 at 12:59 PM | marketbeat.comBeOne Medicines (NASDAQ:ONC) Releases Earnings Results, Beats Expectations By $0.36 EPSAugust 9 at 9:20 AM | marketbeat.comRoyal Bank Of Canada Issues Positive Forecast for BeOne Medicines (NASDAQ:ONC) Stock PriceAugust 8 at 11:52 AM | marketbeat.comBeOne Medicines (NASDAQ:ONC) Stock Price Expected to Rise, Guggenheim Analyst SaysAugust 8 at 10:33 AM | marketbeat.comBeOne Medicines Ltd. (NASDAQ:ONC) Q2 2025 Earnings Call TranscriptAugust 7 at 9:01 AM | msn.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Receives $327.56 Average PT from AnalystsAugust 7 at 3:39 AM | americanbankingnews.comInsider Selling: BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) CFO Sells 1,190 Shares of StockAugust 6, 2025 | marketbeat.comBeOne Medicines outlines $5B–$5.3B 2025 revenue target as BRUKINSA leads BTK market and global expansion acceleratesAugust 6, 2025 | msn.comBeOne Medicines (NASDAQ:ONC) Hits New 52-Week High - Here's WhyAugust 6, 2025 | marketbeat.comBeOne Medicines Ltd. (ONC) Q2 2025 Earnings Call TranscriptAugust 6, 2025 | seekingalpha.comBeOne Medicines Ltd. 2025 Q2 - Results - Earnings Call PresentationAugust 6, 2025 | seekingalpha.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Given Consensus Recommendation of "Buy" by BrokeragesAugust 3, 2025 | marketbeat.comLai Wang Sells 259 Shares of BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) StockAugust 1, 2025 | marketbeat.comInsider Selling: BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) SVP Sells 920 Shares of StockAugust 1, 2025 | marketbeat.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Insider Lai Wang Sells 4,041 SharesAugust 1, 2025 | marketbeat.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Insider Lai Wang Sells 259 SharesAugust 1, 2025 | insidertrades.comBeOne Medicines (NASDAQ:ONC) Reaches New 12-Month High - Here's WhyJuly 30, 2025 | marketbeat.comBeOne Medicines' Tevimbra Gets CHMP Positive OpinionJuly 28, 2025 | marketwatch.comBeOne Medicines shares climb following positive EU backing for lung cancer therapyJuly 28, 2025 | msn.comBeOne Medicines Ltd.: BeOne Medicines Receives Positive CHMP Opinion for TEVIMBRA in Neoadjuvant/Adjuvant NSCLC TreatmentJuly 28, 2025 | finanznachrichten.deWall Street Zen Upgrades BeOne Medicines (NASDAQ:ONC) to BuyJuly 26, 2025 | marketbeat.comBeOne Medicines Ltd. (ONC) Wins EU Nod for TevimbraJuly 25, 2025 | msn.comLai Wang Sells 700 Shares of BeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) StockJuly 23, 2025 | marketbeat.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Insider Lai Wang Sells 700 SharesJuly 23, 2025 | insidertrades.comThe S&P 500 and Nasdaq Are Joined By These Stocks Hitting New HighsJuly 18, 2025 | msn.comJPMorgan Chase & Co. Forecasts Strong Price Appreciation for BeOne Medicines (NASDAQ:ONC) StockJuly 18, 2025 | marketbeat.comBeOne Medicines (NASDAQ:ONC) Hits New 52-Week High on Analyst UpgradeJuly 17, 2025 | marketbeat.comLooming Tariffs Don't Scare This Swiss Cancer Treatment StockJuly 16, 2025 | msn.comRoyal Bank Of Canada Increases BeOne Medicines (NASDAQ:ONC) Price Target to $349.00July 16, 2025 | marketbeat.comBeOne Medicines to Announce Second Quarter 2025 Financial Results on August 6July 16, 2025 | businesswire.comBeOne Medicines (NASDAQ:ONC) Shares Gap Up - Here's WhyJuly 15, 2025 | marketbeat.comBiocytogen Enters into Antibody Licensing Agreement with BeOne ...July 13, 2025 | businesswire.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) CEO John Oyler Sells 27,802 SharesJuly 12, 2025 | insidertrades.comBeOne Medicines (NASDAQ:ONC) Cut to Hold at Wall Street ZenJuly 12, 2025 | marketbeat.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) CEO Sells $7,044,470.76 in StockJuly 11, 2025 | marketbeat.comBeOne Medicines Ltd. American Depositary Shares (ONC) Insider ActivityJuly 11, 2025 | nasdaq.comEuropean Commission Approves TEVIMBRA® in Combination with Chemotherapy as a First-Line Treatment for Nasopharyngeal CarcinomaJuly 10, 2025 | businesswire.comBiocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug DevelopmentJuly 9, 2025 | businesswire.comBiocytogen Enters into Antibody Licensing Agreement with BeOne Medicines to Accelerate Innovative Drug DevelopmentJuly 9, 2025 | businesswire.comONC BeOne Medicines Ltd. - Seeking AlphaJuly 8, 2025 | seekingalpha.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Receives Consensus Rating of "Buy" from BrokeragesJuly 8, 2025 | marketbeat.comThis Startup Built A Hospital In India To Test Its AI SoftwareJuly 2, 2025 | forbes.comBeOne Medicines (NASDAQ:ONC) Shares Gap Down - Time to Sell?June 27, 2025 | marketbeat.comMorgan Stanley Forecasts Strong Price Appreciation for BeOne Medicines (NASDAQ:ONC) StockJune 27, 2025 | marketbeat.comBeOne Medicines (NASDAQ:ONC) Price Target Raised to $321.00June 27, 2025 | marketbeat.comBeOne Medicines (NASDAQ:ONC) Receives "Outperform" Rating from Royal Bank Of CanadaJune 27, 2025 | marketbeat.comBeOne Medicines Ltd.: BeOne Medicines to Host Investor R&D Day Webcast on June 26, 2025 - FinanzNachrichten.deJune 26, 2025 | finanznachrichten.deBeOne Medicines (NASDAQ:ONC) Stock Price Down 3.6% on Insider SellingJune 26, 2025 | marketbeat.comBeOne Medicines Ltd. - Sponsored ADR (NASDAQ:ONC) Insider Lai Wang Sells 1,028 SharesJune 26, 2025 | insidertrades.com Get BeOne Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. Email Address ONC Media Mentions By Week ONC Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ONC News Sentiment▼0.520.50▲Average Medical News Sentiment ONC News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ONC Articles This Week▼177▲ONC Articles Average Week Get BeOne Medicines News Delivered to You Automatically Sign up to receive the latest news and ratings for ONC and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SNY News GSK News TAK News ARGX News BNTX News INSM News SMMT News TEVA News GMAB News RDY News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ONC) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredAltucher: $900 to $108,000? Trump’s “Great Gain” Is HereJames Altucher says two recent events could trigger a historic wealth shift—one driven by a radical Trump poli...Paradigm Press | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredTake a look at this picture ...A strange investment secret — discovered just a few short weeks before this image was taken — correctly predic...Weiss Ratings | SponsoredNational 'Stock Market Reset' Coming September 30 (New WH Order)Crash Coming Sept 30? Analysts Warn of New Crisis A new problem on the U.S. power grid is putting millions ...Altimetry | SponsoredFed Decision Warning: How to Protect Your Wealth Before September 17th On September 17th, the Fed faces an impossible choice—and Wall Street insiders are already preparing for the...American Alternative | SponsoredSell this, buy thatWhat you don’t own matters just as much as what you do. That’s the thinking behind Eric Fry’s long-time strate...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BeOne Medicines Ltd. - Sponsored ADR Please log in to your account or sign up in order to add this asset to your watchlist. Share BeOne Medicines With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ONC Stock Alerts